Marathon of Hope Cancer Centres Network Seminar Series: Presented by the MOH-Q

Updates from leadership and researchers at the Marathon of Hope - Quebec consortium held in April 2024.

<div style="padding:42.2% 0 0 0;position:relative;"><iframe src="https://player.vimeo.com/video/944533179?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture; clipboard-write" style="position:absolute;top:0;left:0;width:100%;height:100%;" title="Marathon of Hope Cancer Centres Network Seminar Series: Presented by the MOH-Q"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>
Updates from leadership and researchers at the Marathon of Hope - Quebec consortium held in April 2024. 

*Please note that Dr. Elkrief's presentation has been removed as it contained unpublished data.

MOH-Q CONSORTIUM ACTIVITIES UPDATE

Anne-Marie Mes-Masson, PhD, FRSC, FCAHS - Professor, Department of Medicine, Université de Montréal; Associate Scientific Director, Basic and Translational Research, Centre de recherche du Centre hospitalier de l'Université de Montréal (CR-CHUM); MOHCCN consortium lead (MOH-Q)

Morag Park, CQ, PhD, FRSC, FCAHS - Distinguished James McGill Professor, Departments of Oncology, Biochemistry, and Medicine, McGill University; Diane and Sal Guerrera Chair in Cancer Genetics; Director, Rosalind and Morris Goodman Cancer Institute, McGill University; MOHCCN consortium lead (MOH-Q)

 
RESEARCH PRESENTATIONS

Role of gut and intratumoral microbiota on response to immune checkpoint inhibitors in lung cancer and melanoma

Arielle Elkrief, MD, FRCPC - Assistant Professor, Department of Hematology-Oncology, Université de Montréal; Medical Director, CHUM Microbiome Centre; MOHCCN cohort lead

View abstract and plain language summary

 

Using unsupervised clustering of multiomic data to define molecular and transcriptional subtypes of rare pancreatic neuroendocrine tumours

Joan Miguel Romero, MSc - MD-PhD Candidate, Division of Experimental Medicine, Rosalind and Morris Goodman Cancer Institute and Research Institute of the McGill University Health Centre (RI-MUHC), McGill University

View abstract and plain language summary

 

This event was co-chaired by Natalie A-K, BSc, MBA, CPA-CMA, de novo stage 4 breast cancer patient, MOHCCN Patient Working Group and Network Council member, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.